{"id":10695,"date":"2026-01-20T16:06:08","date_gmt":"2026-01-20T16:06:08","guid":{"rendered":"https:\/\/palynziqpatient-prod-001.azurewebsites.net\/en-us\/?page_id=10695"},"modified":"2026-04-07T11:11:09","modified_gmt":"2026-04-07T11:11:09","slug":"diet-flexibility","status":"publish","type":"page","link":"https:\/\/palynziq.biomarin.com\/en-us\/diet-flexibility\/","title":{"rendered":"PALYNZIQ and Diet Flexibility"},"content":{"rendered":"
\n
\n
\n
<\/div>\n
<\/div>\n \n
\n
\n \"\" <\/div>\n\n

Playing to win<\/br> and taking PALYNZIQ<\/p>\n <\/div>\n \n

\n
\n

Diet or no diet\u2014you can start PALYNZIQ<\/h1>\n \n

PALYNZIQ is the first and only PKU treatment proven to lower Phe levels without requiring a restricted diet.<\/p>\n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n

\n
\n
\n \n
\n

In the clinical study, most people did NOT consume a Phe-restricted diet while taking PALYNZIQ<\/h2>\n

A Phe-restricted diet is when people get over 75% of protein intake from medical food.<\/p>\n <\/div>\n\n

\n\t
\n\t\t
\n\t\t\t
\n\t\t\t\t
\n

A separate analysis of the 250 adults taking PALYNZIQ during the clinical study* found that:\n<\/h3>\n <\/div>\n \t\t\t\t\n
\n
\n
\n\t\t\t \"84%\t\t\t<\/div>\n\t\t\t
\n\t\t\t \"84%\t\t\t<\/div>\n <\/div>\n <\/figure>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n

 <\/p>\n

*A separate analysis of the results from the clinical trial (N=250) showed that:<\/small><\/p>\n